Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial - Wikidata - wikimedia - TriplyDB

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

http://www.wikidata.org/entity/Q34724039

about

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.

P2860

Q33891810-4223877F-4429-422B-9DE7-C2CFD9D026ED Q34505582-EEB0DE8D-2FC0-4AC6-8A27-40AFB937D83B Q36396614-B7870D93-0BED-45BE-8FFD-780065FA50AD Q38811035-FB9ABAFB-9B43-4A1D-B4B5-5C7D8566C395

P2860

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

http://www.wikidata.org/entity/Q34724039

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Intravenous anidulafungin foll ...... an open-label Phase III trial

@ast

Intravenous anidulafungin foll ...... an open-label Phase III trial

@en

Intravenous anidulafungin foll ...... an open-label Phase III trial

@nl

type

label

Intravenous anidulafungin foll ...... an open-label Phase III trial

@ast

Intravenous anidulafungin foll ...... an open-label Phase III trial

@en

Intravenous anidulafungin foll ...... an open-label Phase III trial

@nl

prefLabel

Intravenous anidulafungin foll ...... an open-label Phase III trial

@ast

Intravenous anidulafungin foll ...... an open-label Phase III trial

@en

Intravenous anidulafungin foll ...... an open-label Phase III trial

@nl

P1433

Q34724039-0CC67E47-AA4F-4B66-B6B0-E8B5C94B7FA5

P1476

Q34724039-5EB1EED6-D95C-4BBD-A230-36106579FB2D

P2093

Q34724039-3076B146-6EE3-4BC6-B2C9-38A5A683A3EB

Q34724039-5060C581-7BEA-43C9-B900-4FFEB42011F7

Q34724039-7E12C66A-95CD-42DA-A870-06DFB582976F

Q34724039-A9CA4432-4F5A-4D1B-9FF4-0B4665921D57

Q34724039-F0744051-4C30-4DA9-81F8-6AD23A2AC113

P2860

Q34724039-02EE415C-217C-48FD-8253-8005F679527F

Q34724039-107F5411-C7E3-4191-A9C3-1C4FC918A2B9

Q34724039-12411AB1-A3ED-4BA6-B505-1F0A1F6E9B28

Q34724039-22EA89FF-168D-4198-99B9-4A69D2C0E16B

Q34724039-248FC53B-91B2-453F-A185-1CE1AC586F70

Q34724039-2A5AFF6C-FA97-4A16-A4A5-2DA027B8B3B1

Q34724039-37A92F79-DCD7-4A45-A926-00D4F1828EFB

Q34724039-39BA9450-A6E6-432F-9629-37B5B31EA7CA

Q34724039-3F586B40-E32D-4EB0-9D9E-755818751B49

Q34724039-460D0F1B-5546-4592-9EBF-E198283EF7DD

P2888

Q34724039-280044D5-EBF1-465B-815E-44C47752001D

P304

Q34724039-4B39CDC9-1115-4BEE-845A-D804BD468C32

P31

Q34724039-93C050F6-FC29-454D-821F-E24D0F052D15

P356

Q34724039-6068CBF8-E317-4B6A-8F0D-C7F95082919A

P478

Q34724039-A4814D6D-9F1C-432E-A1F9-A43B5C195DB8

P50

Q34724039-F2A58838-32F3-4718-90B4-2C291FB0EB22

P577

Q34724039-13C9AC48-206E-4CEA-8F36-A60C013229CA

P5875

Q34724039-83CB6634-834F-4B17-8E06-CF527CBF9076

P6179

Q34724039-A0394954-8135-44B2-A2DC-EC14FA66CDAE

P698

Q34724039-8B5F45D4-EE0F-41BA-8223-C1079D329D34

P921

Q34724039-FA4EAE66-7C93-484C-94A3-23351775E7B5

P932

Q34724039-9E19AA53-23BF-45E6-99CD-055C75B99C49

P356

1471-2334-13-219

P1433

BMC Infectious Diseases

P1476

Intravenous anidulafungin foll ...... an open-label Phase III trial

@en

P2093

Deepak Talwar

http://www.w3.org/2001/XMLSchema#string

Moh-Lim Ong

http://www.w3.org/2001/XMLSchema#string

Piroon Mootsikapun

http://www.w3.org/2001/XMLSchema#string

Vilma M Co

http://www.w3.org/2001/XMLSchema#string

Viraj Rajadhyaksha

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

Epidemiology of invasive candidiasis: a persistent public health problem

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Anidulafungin versus fluconazole for invasive candidiasis.

Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.

P2888

1471-2334-13-219

P304

219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-219

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236910888

http://www.w3.org/2001/XMLSchema#string

P6179

1031167427

http://www.w3.org/2001/XMLSchema#string

P698

23676114

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

3659089

http://www.w3.org/2001/XMLSchema#string